Does Occipital Nerve Stimulation Alter Pain Response as Measured by Quantitative Sensory Testing in Patients With Chronic Migraine or Cluster Headache

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary aim of this study is to assess the reversibility of a range of psychophysical markers of pain processing in patients with chronic migraine or cluster headache before and after ONS insertion and comparing to patients having a general anaesthetic (GA) for a non-painful aetiology at Barts Health NHS Trust. We will also compare with healthy volunteers not undergoing surgery. To establish whether pain perception alters in patients with chronic migraine/cluster headache having ONS using questionnaires and compare to patients having a general anaesthetic for a non- painful procedure D \& C at Barts Health NHS Trust. Are pain markers (Glutamate, TGF-B1) altered with ONS?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Subject satisfies standard criteria in the study centre for ONS implantation and the NICE 452 criteria for intractable chronic migraine or cluster headache.

• Patients who have given their written informed consent.

• Patient is able and willing to comply with study procedures and follow up schedule.

• Participants will need a good understanding of the English Language and hence. This is a requirement not just for this research but also for the success of the interventions and the full understanding of QST.

• Patients undergoing surgery (non-painful complaint) 'dilatation and curettage' (D\&C).

Locations
Other Locations
United Kingdom
Barts health NHS Trust
RECRUITING
London
Contact Information
Primary
Theresa Wodehoise
theresa.wodehouse@nhs.net
07866813990
Backup
Vivek mehta, FRCA MD FFP MRC
Time Frame
Start Date: 2019-09-01
Estimated Completion Date: 2025-11
Participants
Target number of participants: 40
Treatments
Experimental: Quantitative sensory testing
Related Therapeutic Areas
Sponsors
Leads: Barts & The London NHS Trust

This content was sourced from clinicaltrials.gov